Manifold MarketsGeen KYCGeverifieerde afwikkelingsgegevensRedelijk gekalibreerdHuidige gemeenschapsvoorspellingJa 82.6%
Voorspellers
6
Vraagtype
binary
Methodologie
Play-money forecasting platform
Brontype
Voorspelling
Marktdata
Bijgewerkt 18 uur geleden
Verouderd29 jun 25, 18:02 UTC31 dec 26, 23:59 UTC
Trends
Gerelateerde Markten
Gerelateerde vragen voor context, geen vergelijking van gelijkwaardige contracten.
Will Retatrutide (new obesity drug) be FDA approved by the end of 2026?
Manifold MarketsWill Lantern Bioworks Lumina treatment be FDA Approved for preventing tooth decay by the end of 2026?
Manifold MarketsWill Lantern Bioworks Lumina treatment be FDA Approved for preventing tooth decay by the end of 2028?
Manifold MarketsRaniPill microneedle pill to replace injections: approved for sale by the end of 2026?
FutuurTdi-11861 (a fast-acting male contraceptive) approved for human clinical trials by the end of 2026?
FutuurOrion (a device that promises to project artificial vision into the brains of blind people) approved for sale by the end of 2027?
FutuurRegels
This market predicts whether any myostatin inhibitor will receive regulatory approval for any condition by December 31, 2026.
- Myostatin inhibitors are being developed to treat conditions like muscular dystrophy and obesity.
- Notable candidates include Regeneron's trevogrumab and Eli Lilly's bimagrumab.
- Approval status can be verified through official regulatory agency announcements, such as those from the FDA (https://www.fda.gov/).
Open markten
Regulation
POLYMARKETClarity Act (H.R.3633) signed into law in 2026?
- No+2.0pt86%
- Yes-2.0pt14%
- Totaal volume
- € 12,5 mln.
- 24u volume
- € 248,7K
KALSHIWill the Clarity Act become law?
- Before Oct 1, 2027-14.0pt40%
- Before Jan 1, 2028-15.0pt38%
- Before Jul 1, 2027-15.0pt32%
+7 extra uitkomsten
POLYMARKETAnthropic IPO by which date?
- December 31,+3.0pt90%
- December 15,86%
- November 30,-1.0pt84%
+7 extra uitkomsten
- Totaal volume
KALSHIWhen will Anthropic officially announce an IPO?
- Before Apr 1, 2027+5.0pt97%
- Before Jan 1, 2027+1.0pt96%
- Before Mar 1, 2027-1.0pt94%
+9 extra uitkomsten
KALSHIWhen will Tesla and SpaceX merge?
- Before 2028-2.0pt63%
- Before Apr 1, 2027-1.0pt51%
- Before May 1, 2027-5.0pt49%
+8 extra uitkomsten
POLYMARKETWhat will OpenAI's IPO valuation be?
- $1.25T–$1.5T20%
- $1.75T–$2.0T19.1%
- $1.5T–$1.75T18.1%
+5 extra uitkomsten
- Totaal volume
- € 96,6K
- How many states will adopt data center moratoriums in 2026?
- Conference to Win the National Championship
- Will California authorize an alternative wage or other qualifying relief from goat-herder wage and overtime obligations before Oct 1, 2026?
- Which companies will officially announce an IPO this year?
- Discord IPO Closing Market Cap
- Will another state enact a data center moratorium in 2026?
- Which Senators will vote for the Clarity Act?
- Will Wyoming create a Digital Asset Authority?
- SpaceX' Market Cap end of October 2026?
- When will the Senate vote on the Clarity Act?
Veelgestelde vragen
- Wat zijn de huidige kansen voor Any myostatin inhibitor FDA approved by 2027?
- Manifold Markets prijst Yes op 83% per 8 september 2026.
- Wanneer wordt Any myostatin inhibitor FDA approved by 2027 afgewikkeld?
- Any myostatin inhibitor FDA approved by 2027 wordt naar verwachting op 31 december 2026 afgewikkeld.
- Hoe wordt Any myostatin inhibitor FDA approved by 2027 afgewikkeld?
- Manifold Markets wikkelt deze markt als volgt af: This market predicts whether any myostatin inhibitor will receive regulatory approval for any condition by December 31, 2026.